Roche to Develop Companion Diagnostic Test for Dalcetrapi
Roche, a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics, has signed an agreement to develop a […]
Say something
Tags: Business/Finance, Cardiovascular disease, CEO, CHF, CHUGAI PHARMACEUTICAL CO. LTD., clinical trial, DalCor Pharmaceuticals, FDA, GENENTECH INC., Head, Health/Medical/Pharmaceuticals, Hoffmann-La Roche, Japan, leader, M&A, majority shareholder, Paul Brown, personalized healthcare, Pharmaceutical industry in the People's Republic of China, Pharmaceutical sciences, pharmaceuticals, Pharmacology, research, research-focused healthcare, Robert McNeil, Roche, Roche Diagnostics, Roche Holding Ltd, Roche Molecular Diagnostics, science, United States
Cobas KRAS Mutation Test by Roche Receives FDA Approval
Switzerland-based biotech company Roche has announced that it has received the U.S. Food and Drug Administration (FDA) approval for cobas […]
Roche obtains FDA 510(k) Approval for Cobas
Roche’s cobas MRSA/SA Test has received 510(k) approval from the US Food and Drug Administration (FDA) for the early and […]
-
-
Flipkart Health+ App Launched
06-04-2022
